Joseph Edelman – NBIX history
- Issuer:
- NEUROCRINE BIOSCIENCES INC
- Quarters tracked:
- 40 (Q2 2016 → Q1 2026)
- Current shares:
- 65,050
- Current value:
- $8.57M
- Peak shares:
- 5,151,589 (Q4 2017)
- Overall change:
- -98%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q1 2026 | 65,050 | $8.57M | $131.74 | -266,000 | -80% |
| Q4 2025 | 331,050 | $46.95M | $141.83 | -119,000 | -26% |
| Q3 2025 | 450,050 | $63.18M | $140.38 | +195,000 | +76% |
| Q2 2025 | 255,050 | $32.06M | $125.69 | +155,000 | +155% |
| Q1 2025 | 100,050 | $11.07M | $110.60 | 0 | 0% |
| Q4 2024 | 100,050 | $13.66M | $136.50 | -112,178 | -53% |
| Q3 2024 | 212,228 | $24.45M | $115.22 | -437,681 | -67% |
| Q2 2024 | 649,909 | $89.47M | $137.67 | -154,500 | -19% |
| Q1 2024 | 804,409 | $110.94M | $137.92 | +533,615 | +197% |
| Q4 2023 | 270,794 | $35.68M | $131.76 | +111,552 | +70% |
| Q3 2023 | 159,242 | $17.91M | $112.50 | +59,192 | +59% |
| Q2 2023 | 100,050 | $9.44M | $94.30 | 0 | 0% |
| Q1 2023 | 100,050 | $10.13M | $101.22 | 0 | 0% |
| Q4 2022 | 100,050 | $11.95M | $119.44 | 0 | 0% |
| Q3 2022 | 100,050 | $10.63M | $106.21 | -297,838 | -75% |
| Q2 2022 | 397,888 | $38.79M | $97.48 | +2,249 | +1% |
| Q1 2022 | 395,639 | $37.09M | $93.75 | -87,368 | -18% |
| Q4 2021 | 483,007 | $41.14M | $85.17 | 0 | 0% |
| Q3 2021 | 483,007 | $46.33M | $95.91 | -328,825 | -41% |
| Q2 2021 | 811,832 | $79.01M | $97.32 | -130,000 | -14% |
| Q1 2021 | 941,832 | $91.59M | $97.25 | -957,383 | -50% |
| Q4 2020 | 1,899,215 | $182.04M | $95.85 | +350,500 | +23% |
| Q3 2020 | 1,548,715 | $148.92M | $96.16 | -592,695 | -28% |
| Q2 2020 | 2,141,410 | $261.25M | $122.00 | -921,853 | -30% |
| Q1 2020 | 3,063,263 | $265.13M | $86.55 | -549,291 | -15% |
| Q4 2019 | 3,612,554 | $388.31M | $107.49 | -447,346 | -11% |
| Q3 2019 | 4,059,900 | $365.84M | $90.11 | +36,038 | +1% |
| Q2 2019 | 4,023,862 | $339.73M | $84.43 | +265,200 | +7% |
| Q1 2019 | 3,758,662 | $331.14M | $88.10 | -849,892 | -18% |
| Q4 2018 | 4,608,554 | $315.36M | $68.43 | -168,700 | -4% |
| Q3 2018 | 4,777,254 | $587.36M | $122.95 | +62,004 | +1% |
| Q2 2018 | 4,715,250 | $463.23M | $98.24 | -46,739 | -1% |
| Q1 2018 | 4,761,989 | $394.91M | $82.93 | -389,600 | -8% |
| Q4 2017 | 5,151,589 | $399.71M | $77.59 | +360,000 | +8% |
| Q3 2017 | 4,791,589 | $293.63M | $61.28 | +1,214,000 | +34% |
| Q2 2017 | 3,577,589 | $164.57M | $46.00 | +211,059 | +6% |
| Q1 2017 | 3,366,530 | $145.77M | $43.30 | +50,007 | +2% |
| Q4 2016 | 3,316,523 | $128.35M | $38.70 | +840,251 | +34% |
| Q3 2016 | 2,476,272 | $125.40M | $50.64 | -321,695 | -11% |
| Q2 2016 | 2,797,967 | $127.17M | $45.45 | — | NEW |